Skip to content
See the World Through ScienceA project of ALLATRA
Source: Peer-reviewedJAMA Neurology1 source

A Puzzle About Smoking and Parkinson's Points to a Gas in the Breath

Science

Republish this story

Our work is licensed under Creative Commons BY-NC 4.0. You may republish this piece for free — with credit to ALLATRA Media and a link to the original, unedited beyond length trims, and not for commercial use.

Read the full license

A hand holds a small breath carbon monoxide monitor whose screen reads 20 ppm and 3.8 percent COHb, with red indicator lights lit along both sides of the display.
A hand-held breath carbon monoxide monitor of the kind used to read exhaled CO in parts per million, the measurement this study analyzed. Illustrative image, not from the study."File:Breath CO Monitor.jpg" by Haddy1, via wikimedia, CC-BY-SA-3.0 · CC-BY-SA-3.0

Among Chinese adults who had never smoked, those with more carbon monoxide in their breath went on to develop Parkinson's disease less often than those with less, a team led from the University of Oxford and Peking University reports in JAMA Neurology. The result is an association measured in people followed over time, not evidence that the gas prevents the disease.

The authors describe the finding as pointing to a potentially protective role for carbon monoxide in how Parkinson's develops, one that helps explain a link epidemiologists have recorded for decades: people who smoke are diagnosed with Parkinson's less often than people who do not. On that reading, they write, the result supports clinical trials of carbon monoxide now under way as a treatment for the disease.

The analysis draws on the China Kadoorie Biobank, which measured the carbon monoxide in each participant's breath when they enrolled. Among the 512,701 people in the main analysis, 1,131 developed Parkinson's over roughly 12 years of follow-up, tracked through national death and disease registries and health insurance records.

Regular smoking, in the same group, was associated with a risk of Parkinson's about 30% lower than among people who had never smoked (adjusted hazard ratio 0.70). It was also associated with higher risks of lung cancer, ischemic heart disease, stroke and death from any cause.

Among the never-smokers, 675 of whom developed Parkinson's, the risk fell as breath carbon monoxide rose. Set against participants below 2.0 parts per million, those in the three highest bands were 32% to 38% less likely to be diagnosed, and the decline across the range was statistically significant, the team reports.

Higher breath carbon monoxide was not associated with the diseases smoking causes, nor with other neurodegenerative diseases. The association with Parkinson's was stronger among women who had never smoked. First author Clara Bueno Lopez and senior author Zhengming Chen, both at Oxford's Nuffield Department of Population Health, and colleagues adjusted for factors including household solid fuel use and secondhand smoke.

Sources

Spot an error?

Spot an error?

Report an error

Spotted a mistake on this page? Tell us what's wrong and our editors will take a look.

What kind of problem?

Only if you'd like us to be able to follow up. We won't use it for anything else.

We correct mistakes openly. Select any text to flag it. Fixes are logged under our Corrections Policy.

Report an error

Reporting on

A Puzzle About Smoking and Parkinson's Points to a Gas in the Breath

What kind of problem?

Only if you'd like us to be able to follow up. We won't use it for anything else.

We read every report. Corrections are logged publicly.